216 related articles for article (PubMed ID: 12368917)
1. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
3. [A proposal for the rational use of the PET in oncology].
Borrego Dorado I; Vázquez Albertino R
Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of PET in oncology.
Rohren EM; Turkington TG; Coleman RE
Radiology; 2004 May; 231(2):305-32. PubMed ID: 15044750
[TBL] [Abstract][Full Text] [Related]
5. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
6. [Positron-emission tomography in oncology].
Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
Czech N; Brenner W; Kampen WU; Henze E
Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
[No Abstract] [Full Text] [Related]
8. Positron emission tomography for benign and malignant disease.
Visioni A; Kim J
Surg Clin North Am; 2011 Feb; 91(1):249-66. PubMed ID: 21184913
[TBL] [Abstract][Full Text] [Related]
9. Development of oncology protocol using fluorine-18-FDG: one center's experience.
Cronin V; Galantowicz P; Nabi HA
J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of (18)F-FDG in oncology.
Nabi HA; Zubeldia JM
J Nucl Med Technol; 2002 Mar; 30(1):3-9; quiz 10-1. PubMed ID: 11948260
[TBL] [Abstract][Full Text] [Related]
11. PET/CT in oncology: for which tumours is it the reference standard?
Collins CD
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085
[TBL] [Abstract][Full Text] [Related]
12. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Scott WJ; Shepherd J; Gambhir SS
Ann Thorac Surg; 1998 Dec; 66(6):1876-83; discussion 1883-5. PubMed ID: 9930463
[TBL] [Abstract][Full Text] [Related]
14. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
15. PET in oncology: will it replace the other modalities?
Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
[TBL] [Abstract][Full Text] [Related]
16. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke D
J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography scanning is coming to a hospital near you soon!
Bashir H; Shabo G; Nunan TO
Clin Med (Lond); 2008 Apr; 8(2):134-9. PubMed ID: 18478853
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
19. PET scanning said to save money and improve staging of lung cancer.
Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
[No Abstract] [Full Text] [Related]
20. [Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan].
Kubota K; Yamada S; Fukuda H; Tanida T; Saitou Y; Takahashi J; Yamada K
Kaku Igaku; 1997 May; 34(5):329-36. PubMed ID: 9248260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]